Drug Injury Law: FDA And MHRA Actions For Gadolinium-Containing Contrast Agents Differ

Contributor		Document

	Tom Lamb Wilmington, NC	Drug Injury Law: FDA And MHRA Actions For Gadolinium-Containing Contrast Agents Differ
	Website - Blog - Twitter	Posted by Tom Lamb on 12.22.17 in Personal Injury
Profile Summary		Document Summary
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescripti...		Drug Injury Law: FDA And MHRA Actions For Gadolinium-Containing Contrast Agents Differ http://www.drug-injury.com/druginjurycom/2017/12/omniscan-recall-magnevist-drug-retention-gadolinium-containing-contrast-agents...